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Abstract
Adipose tissue-derived microvascular fragments (ad-MVF) 
represent promising vascularisation units for bioengineered 
Integra® matrix wound dressing (MWD). However, due 
to the sheet-like structure with small pore sizes, the 
seeding of this matrix with ad-MVF is mainly limited to 
its surface. Integra® flowable wound matrix (FWM) may 
be suitable to achieve a more homogeneous distribution 
and, thus, improved vascularisation, because this gel-like 
matrix allows for the direct admixture of ad-MVF during 
sample preparation. To test this hypothesis, we seeded 
MWD and FWM with an identical number of ad-MVF 
and assessed their distribution and inter-fragment distance 
within both matrices. Moreover, ad-MVF-seeded MWD 
and FWM were implanted into full-thickness skin defects 
within mouse dorsal skinfold chambers to analyse their 
vascularisation, epithelialisation and tissue incorporation 
using intravital fluorescence microscopy, histology and 
immunohistochemistry. Seeded FWM exhibited a more 
homogeneous ad-MVF distribution, when compared to 
MWD. This resulted in a significantly increased inter-
fragment distance, preventing the reassembly of ad-MVF 
into new microvascular networks. Accordingly, the 
vascularisation of FWM was diminished after implantation, 
as indicated by a reduced functional microvessel density 
and blood perfusion. This was associated with a decreased 
tissue incorporation and epithelialisation of the matrix, 
when compared to ad-MVF-seeded MWD. Hence, the 
use of FWM as a carrier system may require a tremendous 
amount of ad-MVF to shorten their inter-fragment distance 
and, thus, to maintain their vascularisation capacity for 
tissue engineering applications.
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Introduction
Autologous split-thickness skin grafting represents the gold 
standard for skin replacement in case of extensive defects 
(MacNeil, 2007). For this purpose, several bioengineered 
matrices have been developed as off-the-shelf dermal skin 
substitutes, such as Integra®, Matriderm® or Glyaderm® 
(Pirayesh et al., 2014; Shahrokhi et al., 2014). In the 
initial phase of treatment, these matrices are directly 
implanted into the debrided wound bed, where they 
provide the required porous structure to allow cellular 
and vascular ingrowth from the surrounding tissue until 
the final coverage with split-thickness skin (Debels et al., 
2015). The kinetics of this biological incorporation process 
crucially determines the risk of wound infection, which is 
elevated as long as the physiological skin barrier function is 
not fully re-established at the defect site (Ruszczak, 2003).
 Recently, we demonstrated that the seeding of Integra® 
matrix wound dressing (MWD) with adipose tissue-derived 
microvascular fragments (ad-MVF) markedly improves 
its epithelialisation, vascularisation and incorporation into 
the host tissue (Frueh et al., 2017). MWD is a clinically 
well-established dermal skin substitute, consisting 
of cross-linked bovine tendon collagen and shark 
glycosaminoglycan (Burke et al., 1981; Reid et al., 2007; 
Graham et al., 2013; Rowan et al., 2015). Of interest, the 
seeding of the matrix with ad-MVF was mainly restricted to 
its surface, because larger ad-MVF could not penetrate its 
small pores (Frueh et al., 2017). Accordingly, in the present 
study, we hypothesised that the seeding of ad-MVF on a 
dermal matrix allowing a more homogeneous distribution 
may result in a faster vascularisation and incorporation, 
when compared to MWD.
 Such a matrix may be Integra® flowable wound matrix 
(FWM), an injectable dermal substitute of identical 
composition to MWD, which has been particularly 
developed for the treatment of complex wounds with 
irregular geometries (Campitiello et al., 2015; Hirche et 
al., 2016). Both MWD and FWM exhibit a comparable in 
vivo biocompatibility and vascularisation (Später et al., 
2016). In contrast to MWD, FWM is delivered as a granular 
compound that, prior to its use, needs to be hydrated with 
sterile saline to obtain a gel-like consistency (Campitiello 
et al., 2015). Therefore, we further hypothesised that this 
sample preparation would allow a more homogeneous 
admixture of ad-MVF into FWM.
 To test our hypotheses, we seeded MWD and FWM 
with an identical number of ad-MVF and assessed their 
distribution and inter-fragment distance within both 
matrices. In addition, the ad-MVF-seeded matrices were 
implanted into full-thickness skin defects within mouse 
269 www.ecmjournal.org
T Später et al.                                                                                                                         Vascularisation of Integra®
dorsal skinfold chambers to analyse their vascularisation, 
epithelialisation and tissue incorporation throughout 
an observation period of 14 d by means of repetitive 
intravital fluorescence microscopy, histology and 
immunohistochemistry.
Materials and Methods
Animals
All animal experiments were approved by the local 
governmental animal care committee (permit number: 
08/2015) and conducted in accordance with the European 
legislation on the protection of animals (Directive 2010/63/
EU) and the NIH guidelines on the care and use of 
laboratory animals (NIH publication #85-23 Rev. 1985).
 Dorsal skinfold chambers were implanted in wild-type 
C57BL/6 mice (Institute for Clinical and Experimental 
Surgery, Saarland University, Homburg, Germany) with 
an age of 4-6 months and a body weight of 24-28 g. 
Epididymal fat was isolated from male green fluorescent 
protein (GFP)+ mice [C57BL/6-Tg(CAG-EGFP)1Osb/J; 
The Jackson Laboratory, Bar Harbor, ME, USA] with 
an age of 12-18 months and a body weight of ≥ 30 g, to 
guarantee large epididymal fat pads containing sufficient 
amounts of ad-MVF for the seeding of the matrices 
(Grässer et al., 2016). The animals were housed under a 
12 h light/dark cycle and were fed ad libitum with water 
and standard food pellets (Altromin, Lage, Germany).
Isolation of ad-MVF
As previously described in detail, ad-MVF were isolated 
from epididymal fat pads of GFP+ donor mice (Frueh et 
al., 2017). Briefly, the bilateral epididymal fat pads were 
removed, transferred into 10 % Dulbecco’s modified 
eagle medium (DMEM; 100 U/mL penicillin, 0.1 mg/mL 
streptomycin; Biochrom, Berlin, Germany) and washed 
thrice with phosphate-buffered saline (PBS). Then, the 
isolated fat tissue was minced and digested for 10 min 
with collagenase NB4G (0.5 U/mL; Serva, Heidelberg, 
Germany) under slow stirring and humidified atmospheric 
conditions (37 °C, 5 % CO2). Subsequently, the digestion 
was neutralised with PBS supplemented with 20 % foetal 
calf serum (FCS) and the cell-vessel suspension was 
incubated for 5 min at 37 °C. Next, the fat supernatant was 
removed and the remaining cell-vessel suspension was 
filtered through a 500 µm mesh. The GFP+ ad-MVF were 
enriched up to a pellet size by a 5 min centrifugation at 
120 ×g. Before that, the ad-MVF were seeded on MWD and 
FWM, the remaining cell-vessel pellet was resuspended 
in 15 µL 0.9 % NaCl.
Seeding of MWD and FWM
MWD samples were identically cut out of a 1.3 mm thick 
Integra® dermal regeneration template single layer without 
silicone sheet (Integra Life Sciences, Ratingen, Germany), 
using a 4 mm biopsy punch (Kai Medical, kaiEurope GmbH, 
Solingen, Germany). Each MWD sample was placed on 
a 500 µm cell strainer and 15 µL 0.9 % NaCl containing 
~15,000 ad-MVF were transferred onto the implant with a 
20 µL pipette (Eppendorf, Wesseling-Berzdorf, Germany). 
To generate an ad-MVF-seeded FWM sample, 1.25 mg of 
the granulated collagen-glycosaminoglycan were carefully 
hydrated with 15 µL of 0.9 % NaCl containing an identical 
number of ad-MVF.
Modified dorsal skinfold chamber model
For the in vivo analysis of the ad-MVF-seeded matrices, we 
used a modified dorsal skinfold chamber model according 
to Sorg et al. (2007; 2009). For the implantation of the 
dorsal skinfold chamber (Irola Industriekomponenten 
GmbH & Co. KG, Schonach, Germany), the mice were 
anaesthetised by intraperitoneal injection of ketamine 
(75 mg/kg body weight; Ursotamin®; Serumwerke 
Bernburg, Bernburg, Germany) and xylazine (25 mg/kg 
body weight; Rompun®, Bayer, Leverkusen, Germany). 
Then, two symmetrical titanium frames were implanted 
on the extended dorsal skinfold, as described previously 
in detail (Laschke and Menger, 2016). After a recovery 
period of 2 d, the mice were anaesthetised again to create 
a 4 mm full-thickness skin defect within the observation 
window of the chamber by means of a dermal biopsy punch 
(Kai Medical) and microsurgical instruments. After the 
defect was filled with either an ad-MVF-seeded MWD 
sample or an identical volume of ad-MVF-seeded FWM, 
the observation window of the chamber was sealed with a 
removable cover glass.
Stereomicroscopy
To assess the epithelialisation of both ad-MVF-seeded 
MWD and FWM by planimetry, the anaesthetised animals 
were fixed on a Plexiglas® stage and the dorsal skinfold 
chamber was positioned under a stereomicroscope (Leica 
M651, Wetzlar, Germany) on day 0 (day of implantation) 
as well as day 3, 6, 10 and 14. The chamber tissue was 
visualised in epi-illumination to identify epithelialised and 
non-epithelialised areas. The microscopic images were 
recorded by a DVD system and quantitatively analysed 
using the CapImage computer-assisted off-line analysis 
system (Zeintl, Heidelberg, Germany). The epithelialised 
area (given in %) was calculated by the equation:
(Total implant area − non-epithelialised implant area)/total 
implant area × 100.
Intravital fluorescence microscopy
After stereomicroscopy, 0.1 mL of the blood plasma marker 
5 % FITC-labelled dextran (150,000 Da; Sigma-Aldrich, 
Taufkirchen, Germany) was injected in the retrobulbar 
venous plexus of the anaesthetised animals for contrast 
enhancement. The observation window of the chamber 
was positioned under a Zeiss Axiotech microscope (Zeiss, 
Oberkochen, Germany) and the microscopic images 
were recorded by a charge-coupled device video camera 
(FK6990; Pieper, Schwerte, Germany) and a DVD system 
for off-line analysis (Laschke et al., 2015).
 The analysis of the microscopic images was performed 
using CapImage (Zeintl). Vascularisation of the implants’ 
surface was assessed in 12 regions of interest (ROIs). ROIs 
exhibiting red blood cell (RBC)-perfused microvessels 
were defined and counted as perfused ROIs (in % of all 
ROIs). The functional microvessel density was determined 
as the length of all RBC-perfused microvessels per area of 
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the ROI (cm/cm2). Moreover, both diameter (d, in µm) and 
centreline RBC velocity (v, µm/s) of 40 randomly selected 
microvessels were measured. These two parameters were 
then used to calculate the wall shear rate (y, in s-1) by means 
of the Newtonian definition y = 8 × v/d (Ampofo et al., 
2016).
Experimental protocol
In a first set of experiments, ad-MVF were harvested from 
3 GFP+ donor mice. Half of the ad-MVF were seeded onto 
3 MWD samples, while the other half was admixed in 3 
FWM samples. Directly after seeding, the samples were 
processed for the histological analysis of the distribution 
and distance of ad-MVF within the matrices.
 For the in vivo analyses, ad-MVF were harvested from 
11 male GFP+ donor mice. Half of the ad-MVF were seeded 
on 11 MWD samples, while the other half was admixed in 
11 FWM samples. Both MWD and FWM samples were 
implanted into full-thickness skin defects in dorsal skinfold 
chambers of 22 wild-type C57BL/6 mice. Vascularisation 
and epithelialisation of 8 implants per group were analysed 
by means of stereomicroscopy and intravital fluorescence 
microscopy on day 0 (day of implantation), 3, 6, 10 and 14. 
Thereafter, the animals were sacrificed with an overdose of 
anaesthesia and the dorsal skinfold chamber preparations 
were processed for histological and immunohistochemical 
analyses. For additional immunohistochemical analyses 
at an earlier time point, 3 animals per group were already 
sacrificed on day 6 after implantation.
Histology and immunohistochemistry
Formalin-fixed specimens of freshly ad-MVF-seeded 
MWD and FWM samples, as well as dorsal skinfold 
preparations with their implants, were embedded in 
paraffin and cut into 3 µm thick sections. Haematoxylin and 
eosin (HE) staining of individual sections was performed 
Fig. 1. HE-stained and immunofluorescent sections of (a, c) ad-MVF-seeded MWD and (b,d) FWM immediately 
after seeding (broken line = implant border; arrows = ad-MVF). The immunofluorescent sections were stained 
with an antibody against CD31 to detect blood vessels (c,d, red) and Hoechst 33342 to detect cell nuclei (c,d, 
blue). Scale bars= 100 µm. (e) cv and (f) inter-fragment distance of ad-MVF-seeded MWD (white bars; n = 3) 
and FWM (black bars; n = 3). Mean ± SEM. * p < 0.05 vs. MWD.
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according to standard procedures. To quantify the collagen 
content of implanted MWD and FWM, additional sections 
were stained with sirius red. Using a BX60 microscope 
(Olympus, Hamburg, Germany) and the imaging software 
cellSens Dimension 1.11 (Olympus), the collagen content 
was assessed in relation to normal skin in 4 ROIs per 
sample (Frueh et al., 2017).
 Freshly ad-MVF-seeded MWD and FWM were 
embedded in Tissue-tek® O.C.T. compound (A. Hartenstein 
GmbH, Würzburg, Germany), quickly-frozen in liquid 
nitrogen at −196 °C and subsequently cut into 3 µm thick 
cryosections. The sections were stained with a monoclonal 
rat anti-mouse antibody against the endothelial cell marker 
CD31 (1 : 100; Dianova, Hamburg, Germany). A goat anti-
rat IgG Alexa555 antibody (Life Technologies, Eugene, 
OR, USA) served as secondary antibody. Cell nuclei were 
stained with Hoechst 33342 (1 : 500; Sigma-Aldrich). 
The sections were examined with a BX60 microscope 
Fig. 2. (a) C57BL/6 mouse with a dorsal skinfold chamber. Scale bar = 13 mm. (b) Overview of the chamber 
observation window with an ad-MVF-seeded MWD implant in a 4 mm full-thickness skin defect (asterisk). 
Scale bar = 1.5 mm. Intravital fluorescence microscopy (blue light epi-illumination with 5 % FITC-labelled 
dextran 150,000 i.v.) of implanted (c-e) ad-MVF-seeded MWD and (f-h) FWM on day 14 (broken line = implant 
border; d,g = insert in c and f; e,h = insert in d and g; arrows = perfused microvessels). Scale bars: c,f = 2 mm; 
d,g = 400 µm; e,h = 100 µm. (i) Perfused ROIs and (j) functional microvessel density of ad-MVF-seeded MWD 
(white bars; n = 8) and FWM (black bars; n = 8). Mean ± SEM. * p < 0.05 vs. MWD.
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(Olympus) to assess the distribution and the distance of 
individual ad-MVF within the samples. For this purpose, 
the number of CD31+ microvessels was determined in 
20 ROIs per implant (equivalent to the entire implant 
area per section), to calculate the coefficient of variation 
(cv; standard deviation/mean) of the spatial fragment 
distribution. Moreover, the inter-fragment distance (given 
in µm) was measured in 5 randomly selected ROIs.
 In addition, dorsal skinfold preparations with their 
implants were co-stained using a monoclonal rat anti-
mouse antibody against the endothelial cell marker 
CD31 (1 : 100; Dianova) and a polyclonal goat antibody 
against GFP (1 : 200; Rockland immunochemicals, 
Limerick, ME, USA). A goat anti-rat IgG Alexa555 
antibody (Life Technologies) and a biotinylated donkey 
anti-goat antibody (1 : 30; Dianova) served as secondary 
antibodies. The biotinylated antibody was detected by 
streptavidin-Alexa488 (1 : 50; Life Technologies). Cell 
nuclei were stained with Hoechst 33342 (1 : 500; Sigma-
Aldrich). Quantitative analyses of the sections included the 
determination of the density of CD31+ microvessels (given 
in mm−2) and the fraction of CD31+/GFP+ microvessels 
(given in %) within the implants.
 For the detection of cleaved caspase-3+ and Ki67+ cells, 
sections were incubated with a rabbit polyclonal anti-
cleaved caspase-3 antibody (1 : 100; New England Biolabs, 
Frankfurt, Germany) or a rabbit polyclonal anti-Ki67 
antibody (1 : 500; Abcam, Cambridge, UK) as primary 
antibody, followed by a biotinylated goat anti-rabbit IgG 
antibody (ready-to-use; Abcam) as secondary antibody. 
The biotinylated antibody was detected by peroxidase-
labelled-streptavidin (1 : 50; Sigma-Aldrich). 3-Amino-
9-ethylcarbazole (Abcam) was used as chromogen. The 
sections were counterstained with Mayer’s haemalum 
(Merck, Darmstadt, Germany). Quantitative analyses of 
the sections included the determination of the fractions 
of cleaved caspase-3+ and Ki67+ cells (given in %) in 6 
randomly selected ROIs within the implants on day 6 and 
14.
 On day 14, for the immunohistochemical detection of 
the cytokeratin+ epithelial layers covering the implants, 
sections of the largest cross-sectional diameter of 
the matrices were incubated with a rabbit polyclonal 
anti-cytokeratin antibody (1 : 100; Abcam) as primary 
antibody, followed by a biotinylated goat anti-rabbit 
IgG antibody (ready-to-use; Abcam). The biotinylated 
antibody was detected by peroxidase-labelled-streptavidin 
(1 : 50; Sigma-Aldrich). 3,3-Diaminobenzidine (Sigma-
Aldrich) was used as chromogen. Using a BZ-8000 
microscopic system (Keyence, Osaka, Japan), the length 
of the cytokeratin+ epithelial layer and the diameter of 
the implants were measured to assess epithelialisation as 
follows:
(Length of cytokeratin+ epithelial layer/total diameter of 
implant) × 100.
Statistical analysis
After testing the data for normal distribution and equal 
variance, differences between the groups were analysed 
by the unpaired Student’s t-test (SigmaStat; Jandel 
Corporation, San Rafael, CA, USA). All values were 
expressed as means ± SEM. Statistical significance was 
accepted for a value of p < 0.05.
Results
Ad-MVF distribution within seeded implants
The examination of HE-stained histological sections of 
freshly seeded MWD and FWM showed that ad-MVF 
were almost exclusively localised on the surface of MWD 
(Fig. 1a), whereas FWM exhibited a more homogeneous 
distribution of the microvessels (Fig. 1b). These 
observations were confirmed by quantitative analyses 
of CD31-stained sections of the matrices. The analyses 
revealed a significantly lower cv for the spatial fragment 
distribution within FWM, when compared to MWD (Fig. 
1c-e). Because both matrices were seeded with ~15,000 
ad-MVF, the more homogeneous distribution within FWM 
also resulted in a ~15 fold higher inter-fragment distance 
(Fig. 1f).
Vascularisation and incorporation of the implants
To analyse the vascularisation of ad-MVF-seeded MWD 
and FWM we used a modified mouse dorsal skinfold 
chamber model (Fig. 2a,b). This model allowed repetitive 
0 d 3 d 6 d 10 d 14 d
Diameter [µm]:
MWD - 27.5 ± 8.6 27.4 ± 2.6 22.3 ± 2.7 18.1 ± 1.5
FWM - 23.3 ± 5.2 32.9 ± 5.4 16.8 ± 0.8* 14.7 ± 0.9
Centreline RBC velocity [µm/s]:
MWD - 150.6 ± 65.9 428.9 ± 111.8 696.4 ± 66.0 643.3 ± 79.2
FWM - 62.5 ± 35.5 101.1 ± 37.6 420.3 ± 89.7 461.9 ± 60.7
Wall shear rate [s-1]:
MWD - 59.6 ± 21.5 136.4 ± 42.7 268.7 ± 37.4 292.9 ± 51.6
FWM - 19.7 ± 7.8 25.8 ± 11.2* 203.3 ± 44.4 250.5 ± 24.3
Table 1. Diameter, centreline RBC velocity and wall shear rate of the microvasculature within ad-MVF-seeded 
MWD (n = 8) and FWM (n = 8) directly (0 d) as well as 3, 6, 10 and 14 d after implantation into dorsal skinfold 
chambers. Mean ± SEM. * p < 0.05 vs. MWD.
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Fig. 3. HE-stained sections of (a,b) ad-MVF-seeded MWD and (c,d) FWM on day 14 (broken line = implant 
border; asterisks = border zones; arrows = panniculus carnosus muscle of the dorsal skinfold chamber prepara-
tion; b,d = insert in a and c). Scale bars: a,c = 350 µm; b,d = 50 µm. (e,f) Immunohistochemical detection of 
CD31+ (red) microvessels (arrows) in (e) ad-MVF-seeded MWD and(f) FWM on day 14. Scale bars = 30 µm. (g) 
Microvessel density of ad-MVF-seeded MWD (white bar; n = 8) and FWM (black bar; n = 8). (h-j) Immunohis-
tochemical detection of microvessels in an ad-MVF-seeded FWM (arrows = CD31+ (red)/GFP+ (green) microves-
sels; arrowhead = CD31+/GFP- microvessel; j = merge of h and i). Scale bars = 15 µm. (k) GFP+ microvessels 
in ad-MVF-seeded MWD (white bar; n = 8) and FWM (black bar; n = 8). (l-n) Polarised light microscopy of 
sirius red stained sections of (l) normal skin, (m) ad-MVF-seeded MWD and (n) FWM. Scale bars = 125 µm. 
(o) Total collagen ratio (implant/skin) of ad-MVF-seeded MWD (white bar; n = 8) and FWM (black bar; n = 8). 
Mean ± SEM. * p < 0.05 vs. MWD.
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intravital fluorescent microscopic analyses of the implants’ 
surface in full-thickness skin defects throughout an 
observation period of 14 d. Our analyses revealed that 
the seeded ad-MVF reassembled into new microvascular 
networks in both experimental groups over time. Also, at 
the borders of the skin defects, these networks developed 
interconnections to the vessels of the surrounding host 
microvasculature, resulting in the onset of blood perfusion. 
Of interest, the pace and extent of this process was 
markedly diminished in implanted FWM samples (Fig. 2c-
h). Accordingly, the FWM group exhibited a significantly 
reduced number of perfused ROIs between day 10 and 
14 and functional microvessel density on day 14, when 
compared to the MWD group (Fig. 2i,j).
 Measurements of microhaemodynamic parameters 
showed that, over time, the diameter of blood-perfused 
microvessels decreased and both the centreline RBC 
velocity and wall shear rate increased in ad-MVF-seeded 
MWD and FWM (Table 1). Although not proven to be 
significant at each time point, the diameter, centreline RBC 
velocity and wall shear rate of microvessels within FWM 
were found to be reduced when compared to MWD (Table 
1).
 In addition, to assess vascularisation and cellular 
infiltration throughout their entire cross section, MWD 
and FWM implants were further examined by means 
of histology and immunohistochemistry at the end of 
the 14 d observation period. The analysis of HE-stained 
sections revealed that most pores of ad-MVF-seeded 
MWD were filled with a dense vascularised granulation 
tissue (Fig. 3a,b). In contrast, vascularisation of FWM 
was only observed in the border zones, while the centre 
of the implants only contained few single cells (Fig. 3c,d). 
Accordingly, the density of CD31+ microvessels was 
significantly reduced within FWM, when compared to 
MWD (Fig. 3e-g). More detailed CD31+/GFP+ co-staining 
analyses of the microvascular networks revealed that 
~93 % of all detected microvessels in MWD originated 
from GFP+ ad-MVF (Fig. 3h-k). This fraction was reduced 
to ~80 % in ad-MVF-seeded FWM (Fig. 3k). To further 
Fig. 4. Immunohistochemical detection of (a,b; arrows) cleaved caspase-3+ and (c,d; arrows) Ki67+ cells in (a,c) 
ad-MVF-seeded MWD and (b,d) FWM on day 6. Scale bars = 50 µm. (e) Cleaved caspase-3+ and (f) Ki67+ cells 
within ad-MVF-seeded MWD (white bars; day 6: n = 3, day 14: n = 8) and FWM (black bars; day 6: n = 3, day 
14: n = 8) on day 6 and 14. Mean ± SEM. * p < 0.05 vs. MWD.
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thus, a repetitive stereomicroscopic analysis of their 
epithelialisation (Fig. 5a-f). This analysis revealed that the 
epithelialisation of ad-MVF-seeded FWM was significantly 
reduced between day 6 and 14, when compared to MWD 
(Fig. 5g). These findings were confirmed by additional 
immunohistochemical analyses of the implants on day 
14, demonstrating that ~75 % of the MWD surface were 
covered with a cytokeratin+ epithelial layer (Fig. 5h,j). 
In contrast, only ~40 % of the FWM surface exhibited a 
cytokeratin+ epithelial coverage (Fig. 5i,j).
Discussion
Bioengineered dermal skin substitutes, such as Integra®, 
provide an off-the-shelf solution for the rapid treatment 
of extensive skin defects. A sufficient vascularisation is 
the major prerequisite for their final coverage with split-
thickness skin grafts after 2-3 weeks (Debels et al., 2015). 
To shorten this critical time period, which is associated with 
an increased risk of wound infection, the seeding of dermal 
substitutes with different cell types has been suggested as 
a promising approach to stimulate the formation of new 
blood vessels within the implants (Lamme et al., 1998; 
Fig. 5. Stereomicroscopic images of skin defects in dorsal skinfold chambers of C57BL/6 mice with (a-c) ad-
MVF-seeded MWD and (d-f) FWM directly after implantation (a,d) as well as on day 6 (b,e) and 14 (c,f) (closed 
line = implant border; broken line = non-epithelialised area). Scale bars = 1.5 mm. (g) Epithelialisation (% of total 
implant area) of implanted ad-MVF-seeded MWD (white bars; n = 8) and FWM (black bars; n = 8). Mean ± SEM. 
* p < 0.05 vs. MWD. (h,i) Immunohistochemical detection of the cytokeratin+ epithelial layer (arrow) covering 
(h) ad-MVF-seeded MWD and (i) FWM on day 14 after implantation. Scale bars = 100 µm. (j) Epithelialisation 
(% of total implant diameter) of ad-MVF-seeded MWD (white bar; n = 8) and FWM (black bar; n = 8). Mean 
± SEM. * p < 0.05 vs. MWD.
analyse the amount of collagen within the implants, a 
sirius red staining was used to detect mature collagen 
type I fibres by their reddish appearance under polarised 
light (Junqueira et al., 1979; Radhika et al., 2016). The 
quantitative analysis of this staining showed a significantly 
lower collagen ratio in FWM, when compared to MWD 
(Fig. 3l-o). Taken together, these results indicated a 
markedly reduced vascularisation and tissue incorporation 
of ad-MVF-seeded FWM.
Apoptotic cell death and proliferation within the 
implants
The immunohistochemical detection of cleaved caspase-3 
and Ki67 showed that ad-MVF-seeded FWM contained a 
significantly higher number of apoptotic cells and reduced 
number of proliferating cells on day 6, when compared 
to MWD (Fig. 4a-f). On day 14, the matrices exhibited 
comparably small numbers of apoptotic and proliferating 
cells, without significant differences between the two 
groups (Fig. 4e,f).
Epithelialisation of the implants
The observation window of the dorsal skinfold chamber 
allowed a continuous access to the implants and, 
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Young et al., 1998; Melendez et al., 2008; Danner et al., 
2012; Meruane et al., 2012; Killat et al., 2013; Zonari 
et al., 2015). Recently, we could demonstrate that the 
seeding of dermal skin substitutes with ad-MVF, which 
already represent fully functional vessel segments, may 
be even more effective (Frueh et al., 2017). Accordingly, 
they only need to develop interconnections with each other 
and the surrounding host microvasculature to get rapidly 
reperfused within a few days (Laschke and Menger, 2015). 
Moreover, ad-MVF also contain mesenchymal stem cells 
and endothelial progenitor cells (Laschke et al., 2012; 
McDaniel et al., 2014). These multipotent cells further 
contribute to their high regenerative potential.
 The seeding of dermal matrices with multi-cellular 
components, such as ad-MVF, is challenging. In fact, these 
matrices typically exhibit small pore sizes (< 200 µm; 
Frueh et al., 2016). This structure has been shown to 
promote the formation of microvascular networks with 
small-diameter vessels with high density and poor 
penetration depth (Choi et al., 2013; Frueh et al. 2016). 
Accordingly, we herein confirmed that ad-MVF were 
almost exclusively localised on the surface of freshly 
seeded MWD, as previously shown (Frueh et al., 2017). In 
contrast, FWM offered the major advantage that ad-MVF 
could be directly admixed into the matrix during the sample 
preparation, leading to a more homogeneous distribution. 
However, against our expectations, this did not result in 
an improved vascularisation and tissue incorporation of 
FWM after implantation into full-thickness skin defects.
 This finding was most probably due to an increased 
inter-fragment distance. In fact, both MWD and FWM were 
seeded with a comparable number of ~15,000 ad-MVF. 
Therefore, the more homogeneous distribution in the FWM 
group was associated with a ~15-fold higher inter-fragment 
distance. Hence, the ad-MVF needed more time to bridge 
the distance between each other. In addition, the reassembly 
of ad-MVF into new microvascular networks has been 
shown to be crucially dependent on the interconnection 
of individual angiogenic sprouts growing out of the vessel 
segments (Nunes et al., 2010). In contrast to FWM, the 
extremely high density of ad-MVF on the surface of MWD 
may have markedly increased the probability for this event 
and the inosculation of the newly developing microvascular 
networks to the surrounding blood vessels of the host 
tissue. Accordingly, the blood perfusion of ad-MVF-
seeded MWD samples was accelerated and improved in 
the early phase after implantation, as indicated by a higher 
centreline RBC velocity and wall shear rate in individual 
microvessels. This, in turn, may have contributed to an 
increased survival rate of the seeded ad-MVF. In line 
with this view, MWD implants exhibited a reduced 
number of apoptotic cells on day 6 as well as an increased 
fraction of CD31+/GFP+ microvessels on day 14, when 
compared to FWM samples. Consequently, histological 
and immunohistochemical analyses at the end of the 
14 d observation period revealed that most pores of ad-
MVF-seeded MWD were filled with a dense vascularised 
granulation tissue. This indicated a good incorporation 
of the matrix into the surrounding tissue, which was 
associated with an increased cellular proliferation rate and 
collagen content as well as an accelerated epithelialisation 
over time, when compared to FWM implants. Hence, these 
findings demonstrated that a locally limited high seeding 
density of ad-MVF was already sufficient to achieve a rapid 
implant vascularisation.
 Finally, it may be assumed that it is also possible to 
further improve the vascularisation of FWM by means 
of ad-MVF. However, for this purpose, a greater number 
of ad-MVF per implant would be necessary to shorten 
their inter-fragment distance and, thus, to maintain their 
ability to reassemble into new microvascular networks. In 
our previous study we have reported that the seeding of 
1 cm² MWD already requires ~120,000 ad-MVF isolated 
from ~3 mL fat tissue (Frueh et al., 2017). Therefore, ad-
MVF-seeded FWM may be particularly recommended 
as an injectable ad-MVF carrier for the minimal invasive 
filling of small, hardly accessible defects with an irregular 
geometry. In contrast, for the coverage of large skin defects, 
such as caused by extensive burns, ad-MVF-seeded MWD 
may be more suitable.
Conclusions
FWM bears the major potential to allow for a more 
homogeneous distribution of cellular material in comparison 
to MWD. However, in case of seeded ad-MVF this is 
associated with an increased inter-fragment distance, which 
prevents the development of new microvascular networks. 
Accordingly, the use of FWM as a carrier system may 
require a tremendous amount of ad-MVF to maintain their 
vascularisation capacity for tissue engineering applications.
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Discussion with Reviewers
Daniel Schmauss: From which region of the body would 
you prefer fat tissue to be obtained, in order to translate 
your study into a clinical setting?
Authors: In the clinical setting, ad-MVF may be minimal-
invasively harvested from a patient by liposuction. 
Since subcutaneous white fat tissue generally exhibits a 
good vascularisation, its origin may not be of particular 
importance. In fact, the body region for the harvesting of 
fat tissue may even be individually chosen according to 
the specific needs of the patient. In most cases it may be 
liposuction of subcutaneous fat from the abdominal wall 
or thighs.
Norbert Pallua: Results are rather descriptive depending 
on the used assay. Thus, the overall relevance of findings 
is limited, since no specific cell line, mechanism/functions 
or novel aspect related to wound healing are discernible.
Authors: We agree with the reviewer that our results are 
rather descriptive. However, although we do not provide 
novel mechanistic insights into the process of wound 
healing, our results may be highly relevant for the future 
clinical application of ad-MVF. In fact, based on our results 
it may be concluded that ad-MVF-seeded FWM may be 
particularly recommended as an injectable ad-MVF carrier 
for the minimal-invasive filling of small, hardly accessible 
defects with an irregular geometry. In contrast, for the 
coverage of large skin defects, such as caused by extensive 
burns, ad-MVF-seeded MWD may be more suitable.
Editor’s note: The Scientific Editor responsible for this 
paper was Christopher Evans.
